New stock first day | GigaDevice Semiconductor Inc. (03986) first listed today, opening 45.06% higher in early trading. The company is a domestic leader in storage chips and MCUs.
Megvii Technology (03986) made its debut on the stock market. The announcement shows that each share was priced at 162 Hong Kong dollars, with a total of 28.9158 million shares issued, and 100 shares per lot. The net proceeds amounted to approximately 4.611 billion Hong Kong dollars. As of the time of writing, the stock price had increased by 45.06% to reach 235 Hong Kong dollars, with a trading volume of 755 million Hong Kong dollars.
GigaDevice Semiconductor Inc. (03986) has been listed for the first time, with an announcement stating that each share is priced at 162 Hong Kong dollars, with a total issuance of 28.9158 million shares, and 100 shares per lot. The net proceeds are approximately 4.611 billion Hong Kong dollars. As of the time of writing, the stock has risen by 45.06%, trading at 235 Hong Kong dollars, with a trading volume of 755 million Hong Kong dollars.
According to the prospectus, GigaDevice Semiconductor Inc. is a diversified integrated circuit design company that provides customers with a variety of chip products including Flash, niche DRAM, microcontrollers, analog chips, and sensor chips. These products are used in various fields such as consumer electronics, automotive, industrial applications (such as industrial automation, energy storage, and battery management), personal computers and servers, internet of things, and network communications to meet customer needs. The company also provides a complete set of systems and solutions including corresponding algorithms and software.
According to Frost & Sullivan, based on revenue in 2024, the company is the only integrated circuit design company in the world that ranks in the top ten globally in the NORFlash, SLCNANDFlash, niche DRAM, and MCU markets. During the historical period, sales of specialty memory chips and MCUs contributed the majority of the company's revenue annually. The company adopts a fabless business model, focusing on IC design and research and development to maintain technological superiority. It also collaborates with high-quality wafer fabs and assembly and test partners to ensure the production of excellent, scalable, and high-quality products.
Related Articles
.png)
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.

HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.
.png)
HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


